期刊文献+

替米沙坦治疗原发性高血压的效果分析 被引量:1

Effect analysis of telmisartan treating essential hypertension
下载PDF
导出
摘要 目的:探讨替米沙坦治疗原发性高血压的临床效果。方法选取2011年12月~2013年9月本院收治的原发性高血压患者138例,将患者随机分成治疗组和对照组,每组各69例。治疗组给予替米沙坦治疗,对照组给予氨氯地平治疗。结果治疗组的总有效率为89.86%,明显高于对照组的69.56%(P〈0.05)。结论替米沙坦治疗原发性高血压能有效控制血压和改善患者的临床症状,值得临床继续推广应用。 Objective To explore the clinical effect of telmisartan treating essential hypertension. Methods 138 pa-tients with essential hypertension were divided into the treatment group (n=69) and the control group (n=69).The treat-ment group was treated with telmisartan,the control group was treated with amlodipine. Results The total effective rate of the treatment group (89.86%) was obviously higher than that in the control group (69.56%) (P〈0.05). Conclusion Telmisartan treating essential hypertension can significantly control blood pressure and improve patients' clinical symp-toms,and it is worthy of clinical continual promotion and application.
出处 《中国当代医药》 2014年第25期118-119,共2页 China Modern Medicine
关键词 原发性高血压 替米沙坦 氨氯地平 效果分析 Essential hypertension Telmisartan Amlodipine Effect analysis
  • 相关文献

参考文献13

二级参考文献76

共引文献72

同被引文献11

  • 1Rheaume C,Arsenault BJ,Despres JP,et al.hnpact of ab- dominal obesity and systemic hypertension on risk of coro- nary heart disease in men and women:the EPIC-Norfolk pop- ulation study[J].J Hypertens, 2014,32 ( 11 ) : 2224-2230.
  • 2Caliskan M,Caliskan Z,Gullu H,et al.Increased morning blood pressure surge and coronary microvascular dysfunc-tion in patient with early stage hypertension [J].J Am Soc Hypertens, 2014,8 (9) :652-659.
  • 3Salisbury D,Bronas U.Inflammation and immune system contribution to the etiology of atherosclerosis:mechanisms and methods of assessment[J].Nurs Res, 2014,63 (5) : 375 - 385.
  • 4Haller H, Cosentino F, Luscher TF.Endothelial dysfunction, hypertension and atherosclerosis.A review of the effects of lacidipine[J].Drugs R D, 2002,3 (5) : 311-323.
  • 5Oalmann MC,Strong JP,Tracy RE,et al.Atherosclerosis in youth :are hypertension and other coronary heart disease risk factors already at work?[J].Pediatr Nephrol, 1997,11 (1) :99-107.
  • 6Xu S, Song H, Huang M ,et al.Telmisartan inhibits the proin- flammatory effects of homocysteine on human endothelial ceils through activation of the peroxisome proliferator-ae- tivated receptor-8 pathway[J].Int J Mol Meal,2014,34(3) : 828-834.
  • 7Benson SC,Pershadsingh HA,Ho CI,et al.Identification of telmisartan as a unique angiotensin Ⅱ receptor antagonist with selective PPAR gamma-modulating activity[J].Hyper- tension, 2004,43 (5) : 993-1002.
  • 8Tennent GA,Hutchinson WL,Kahan MC ,et al.Transgenic hu- man CRP is not pro-atherogenic,pro-atherothrombotic or pro-inflammatory in apoE4-mice[J].Atherosclerosis,2008, 196(1) :248-255.
  • 9Abhashi SA,Kryeziu FU,Nazreku FD,et alIncreased carotid intima-media thickness associated with high hs-CRP lev- els is a predictor of unstable coronary artery disease [J]. Cardiovasc J Afr,2013,24(7) :270-273.
  • 10Wagsater D ,Zhu C ,BjSrkegren J,et al.MMP-2 and MMP-9 are prominent matrix metalloproteinases during atheroscle- rosis development in the Ldlr-/-Apob (100/100)mouse[J]. Int J Mol Med, 2011,28 (2) : 247-253.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部